6 research outputs found
AR staining profiles of normal prostate, primary PCa and CRPC.
<p>(<b>A</b>) IHC staining for N- and C-terminal AR in normal prostate (NP) (a and b), hyperplastic prostate (HP) (c and d) and primary PCa (e-h) (magnification x200). (<b>B</b>) Comparison of AR staining profiles among normal prostate, hyperplastic prostate and primary PCa. (<b>C</b>) Comparison of AR staining profiles between primary PCa and metastatic CRPC.</p
The heterogeneity of AR expression in individual patients.
<p>Multiple metastatic sites of 42 CRPC patients had been analyzed by IHC using 2 AR antibodies. The staining results were summarized as N+C+ (blue), N+C↓ (orange) and N-C- (red). LN = lymph node; L =  lumbar vertebra; R. =  right; L. =  left; T =  thoracic vertebra.</p
Expression of AR variants and AR regulated proteins in metastatic CRPC.
<p>(<b>A</b>) IHC staining for N-terminal AR (a), C-terminal AR (b), PSA (c), PSMA (d), TMPRSS2 (e), AKT-1 (f), Ki-67(g), Negative control (h) on a metastatic CRPC tissue (magnification x200, insert x400). (<b>B</b>) PSA, PSMA, TMPRSS2 and AKT-1 staining profiles of CRPC.</p
Comparison of IHC with RT-PCR results in PCa Metastases.
<p>+Intense expression, ±Limited/weak expression, − No expression.</p
Clinical data of 42 CRPC patients<sup>*</sup>.
<p>*All 42 patients had castrate resistant prostate cancer at the time of autopsy, defined by the presence of a rising serum PSA following medical or surgical castration. All patients' tissues were obtained at autopsy under University of Washington Medical Center Prostate Cancer Donor Rapid Autopsy Program.</p